The Mexico dermatologicals market is evolving as consumers increasingly prioritize skin health, preventive care, and science-backed skincare solutions. The market is projected to grow from USD 580 million in 2025 to USD 660 million by 2032, registering a 1.86% CAGR during 2026–2032. Growing demand for therapeutic skincare products, expanding pharmacy and retail access, and rising interest in gentle, clinically supported formulations are shaping Mexico’s dermatologicals landscape through 2032.